Concepedia

Macaya Douoguih

MD

Statistics

Publications

55

Citations

7.5K

H-Index

33

Active since

2011

Affiliations

Janssen (Netherlands)(Current)

Janssen (Belgium)

London School of Hygiene & Tropical Medicine

Bordeaux Population Health

Inserm

Macaya Douoguih is an author at Janssen (Netherlands) specializing in vaccinology, infectious diseases, and immunization.

ORCID

Publications per year

2011–2024

55

Publications

55

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

, , +17

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

, , +16

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Galit Alter, Jingyou Yu, Jinyan Liu et al. · Nature · 2021 · 352 citations · Full text

, , +16

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Kathryn E. Stephenson, Mathieu Le Gars, Jerald Sadoff et al. · JAMA · 2021 · 336 citations · Full text

, , +17

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 330 citations

, , +17

1–5 of 55